
Conference Coverage
about 1 month ago
APAO 2026: Mark Honor on the Role of PAs as Oncology Care Managersabout 1 month ago
APAO 2026: Jennifer Fisher on Multimodal Care for Brain MetastasesLatest Content

ASTRO 2026: Kayla Kafka-Peterson Advances Global Brachytherapy Nursing Care

On-Body Isatuximab: Clinical Workflows and At-Home Potential in Myeloma

EHR Symptom Data Improve Readmission Risk Prediction After AML Induction

ASTRO 2026: Dr. Nitin Ohri Evaluates Radiation and Systemic Combo Toxicities

Outlining Tiered Self-Care Plans for Oncology Nurses

Shorts










Videos
All News

For Gynecologic Cancer Awareness Month, Amy Schultz, RN, details symptom identification, barrier mitigation, and caregiver support in oncology care.

At ASTRO 2026, DJohn Hillson details how early post-surgical radiation education within 6 weeks improves outcomes for head and neck cancer patients.

Jyoti Malhotra, MD, MPH, joins The Moonlight Shift to discuss first-in-human phase 1 lung cancer trials, healthcare access, and her work at Yale Cancer Center.

Vanderbilt APPs discuss PSA screening, multidisciplinary care, toxicity management, and genetic testing for Prostate Cancer Awareness Month.

Take our quick survey to help Oncology Nursing News improve how we deliver updates across web, video, email, social media, and podcasts.

An FDA advisory panel voted to approve GRAIL's Galleri multi-cancer early detection test for adults 50+. Read key oncology nursing takeaways.

Oncology nurse April Fowler shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance.

Dr. Jason Konner discusses psilocybin, clinician burnout, CIPN prevention, and safety protocols for oncology nurses and care teams in cancer care.

Non-CME PER® Podcast

FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 data and nursing takeaways.

ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.

From ICN 2026, Heather Jackson and Ashley Johnson detail APP breast care access models, global cancer pain barriers, and burnout mitigation tactics.

FDA approves lirafugratinib (Lyrfigtu) for FGFR2+ cholangiocarcinoma. Review REFOCUS trial data, 70 mg daily dosing, and nursing safety guidelines.

Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.

Yesne Alici, MD, of Memorial Sloan Kettering Cancer Center discusses key delirium screening, patient capacity, and bioethics in oncology nursing care.































































